Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Target Audience: The intended audience for the activity is rheumatologists and other health care professionals involved in the management of patients with systemic sclerosis.
Learning Objective: Upon successful completion of this activity, participants should be better able to:
- Evaluate the clinical symptomology and appropriate medical work-up for SSc to better identify patients in a timely manner and refer to a specialist, as warranted.
- Examine the burden of SSc on patient quality of life and the impact of pulmonary involvement on patient outcomes.
- Examine the latest clinical evidence regarding agents for the treatment of SSc, including the impact on skin score, lung function, and quality of life.
- Review the importance of multidisciplinary care for identifying patients with SSc and worsening pulmonary involvement who may benefit from emerging treatment options.
Activity Chair:
Elana J. Bernstein, MD, MSc
Assistant Professor of Medicine
Program Director, Columbia University/New York-Presbyterian Scleroderma Program
Columbia University College of Physicians & Surgeons
New York, NY
Faculty
Richard M. Silver, MD
Distinguished University Professor
Division of Rheumatology
Medical University of South Carolina
Charleston, SC
Elizabeth R. Volkmann, MD, MS
Assistant Professor of Medicine
Founder, Co-director of UCLA CTD-ILD Program
University of California, Los Angeles
David Geffen School of Medicine
Los Angeles, CA
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 17, 2020, to March 16, 2021.
How To Participate in This Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty report the following relationship(s):
Elana J. Bernstein, MD, MSc
Contracted Research: Corbus, Eicos
Advisory Board: Boehringer Ingelheim
Richard M. Silver, MD
Consulting Fee: Boehringer Ingelheim, Bristol-Myers Squibb, Corbus, Forbius
Contracted Research: Boehringer Ingelheim, Cumberland, Genentech
Elizabeth R. Volkmann, MD, MS
Consulting Fee: Boehringer Ingelheim, Forbius
Contracted Research: Corbus, CSL Behring, Forbius
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this CME activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA-approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com